Weis Markets: Revisiting The Premiumization Story
Weis Markets remains a 'Hold' as premiumization boosts margins, but valuation stays near fair value. Gross margin reached 26.3% in Q1, driven by a mix shift to higher-margin products despite only 1.2% same-store sales growth. The pharmacy segment faces pressure from the IRA's maximum fair price rules, impacting revenue and potentially cash flow conversion.